InMode(INMD)
Search documents
Is InMode (INMD) a Great Value Stock Right Now?
ZACKS· 2024-10-14 14:50
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use fundamental analysis and ...
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
Prnewswire· 2024-10-10 11:00
Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 10, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2024 b ...
Should Value Investors Buy InMode (INMD) Stock?
ZACKS· 2024-09-26 14:46
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional va ...
InMode Offers High Risk-Reward Opportunity Amid New Products And Rate Cuts (Rating Upgrade)
Seeking Alpha· 2024-09-19 11:14
I specialize in biotech and healthcare investment analysis, integrating clinical expertise with a solid foundation in business strategy. My approach leverages detailed risk-return charts and DCF analyses to clearly communicate the investment potential and associated risks. I advocate for a barbell portfolio strategy, with 90% allocated to secure assets such as Treasuries and broad-market ETFs, and 10% to high-alpha stocks. This balanced approach ensures that all recommendations are made within a context of ...
Are Investors Undervaluing InMode (INMD) Right Now?
ZACKS· 2024-09-10 14:46
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tried-and-true metrics an ...
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares
Prnewswire· 2024-09-10 11:00
YOKNEAM, Israel, Sept. 10, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has approved a share repurchase program of up to 7.68 million ordinary shares. "Following the completion of our share buyback program announced earlier this year, the board's authorization to enact this new share repurchase program demonstrates our ongoing confidence in the long-term outlook of the company," commented Moshe Mizr ...
InMode Stock: An Inverse Bubble Caused By Short-Term Trouble
Seeking Alpha· 2024-09-06 08:38
Editor's note: Seeking Alpha is proud to welcome Investor's Compass as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » ABRAHAM GONZALEZ FERNANDEZ/E+ via Getty Images InMode (NASDAQ:INMD) stock has been performing horribly in the past three years. Once a $99 stock near the top in 2021, INMD now sits at under $16/share. But i ...
InMode to Present at 2024 Baird Global Healthcare Conference
Prnewswire· 2024-09-04 12:30
YOKNEAM, Israel, Sept. 4, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will present inperson at the 2024 Baird Global Healthcare Conference in New York on Sept. 10, 2024. The fireside chat, moderated by Jeff Johnson, Senior Research Analyst, is scheduled for 2:00 pm Eastern Time on Tuesday, Sept. 10, and a live webcast of the presentation can be accessed here. InMode will also hold oneo ...
InMode to Present at Upcoming Investor Conferences
Prnewswire· 2024-08-06 12:30
YOKNEAM, Israel, Aug. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in August: 9th Annual Needham Virtual MedTech & Diagnostics Conference Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer Format: Virtual one-on-one meetings When: Monday, Aug. 12 Canaccord 44th Annual Global Growth Conference Presenters: Yair Malca, Ch ...
InMode(INMD) - 2024 Q2 - Earnings Call Transcript
2024-08-01 15:19
Start Time: 08:30 January 1, 0000 9:07 AM ET InMode Ltd. (NASDAQ:INMD) Q2 2024 Earnings Conference Call August 01, 2024, 08:30 AM ET Company Participants Moshe Mizrahy - CEO Michael Kreindel - Co-Founder and Chief Technology Officer Yair Malca - CFO Shakil Lakhani - President, North America Eran Krieger - Medical Director and VP of Medical Affairs Rafael Lickerman - Vice President, Finance Miri Segal - CEO, MS-IR Conference Call Participants Danielle Antalffy - UBS Caitlin Cronin - Canaccord Genuity Jeff Jo ...